N 6 -methyladenosine (m 6 A) modification of mRNA is emerging as an important regulator of gene expression that affects different developmental and biological processes, and altered m 6 A homeostasis is linked to cancer 1-5 . m 6 A modification is catalysed by METTL3 and enriched in the 3′ untranslated region of a large subset of mRNAs at sites close to the stop codon 5 . METTL3 can promote translation but the mechanism and relevance of this process remain unknown 1 . Here we show that METTL3 enhances translation only when tethered to reporter mRNA at sites close to the stop codon, supporting a mechanism of mRNA looping for ribosome recycling and translational control. Electron microscopy reveals the topology of individual polyribosomes with single METTL3 foci in close proximity to 5′ cap-binding proteins. We identify a direct physical and functional interaction between METTL3 and the eukaryotic translation initiation factor 3 subunit h (eIF3h). METTL3 promotes translation of a large subset of oncogenic mRNAs-including bromodomain-containing protein 4-that is also m 6 A-modified in human primary lung tumours. The METTL3-eIF3h interaction is required for enhanced translation, formation of densely packed polyribosomes and oncogenic transformation. METTL3 depletion inhibits tumorigenicity and sensitizes lung cancer cells to BRD4 inhibition. These findings uncover a mechanism of translation control that is based on mRNA looping and identify METTL3-eIF3h as a potential therapeutic target for patients with cancer.
the mechanism of translation control and suggest that METTL3-eIF3h and downstream oncogenes could be therapeutic targets for cancer.
To test a mRNA-looping model we first examined whether the METTL3-binding position on mRNA is important for its ability to enhance translation. Using reporters with MS2-binding sites located at different positions (Extended Data Fig. 1a ), we found that direct METTL3 tethering can promote translation only when bound to the 3′ untranslated region (UTR) at a position near the stop codon. In vitro translation assays performed with cell lystates, recombinant METTL3 protein and in vitro-transcribed mRNAs confirmed that full-length METTL3 or an amino-terminal fragment (1-200 amino acids (a.a.)) that is sufficient to promote reporter translation in cells (Extended Data Fig. 2 ) enhanced translation of a luciferase reporter mRNA (Extended Data Fig. 1e-g) . METTL3 tethering had a stronger effect on mRNAs that lack a poly(A) tail (Extended Data Fig. 1g ), which is consistent with some redundancy between METTL3 and eIF4G-PABPC1-mediated looping for mRNAs with poly(A) tails in these in vitro assays.
To provide evidence that METTL3 is bound to polyribosomes, mRNA ribonucleoprotein complexes (mRNPs) containing Flag-METTL3 were affinity purified, incubated with gold-labelled anti-METTL3 antibodies, subjected to sucrose gradient fractionation and then analysed by electron microscopy (Fig. 1a ). This revealed gold-labelled METTL3 in the individual polyribosomes (Extended Data Fig. 4a, b ). We performed similar experiments using either anti-CBP80 or anti-eIF4E gold-labelled antibodies together with the anti-METTL3 particles. As the anti-CBP80 and anti-eIF4E gold particles were larger, they could be distinguished from the anti-METTL3 particles. Individual polyribosomes containing double-labelled gold particles showed that each METTL3 signal is in close proximity (less than 20 nm) to a cap-binding protein (Fig. 1b , Extended Data Fig. 4c, d) . This reveals the topology of individual endogenous METTL3-bound polyribosomes and supports the notion that METTL3 mediates the looping of mRNA to promote efficient translation.
Full-length METTL3 as well as the 1-200 a.a. and 1-350 a.a. fragments were found to associate with m 7 GTP-agarose in cap-binding assays (Extended Data Fig. 3a ). This result is highly consistent with tethering assays (Extended Data Fig. 2 ) and supports the notion that the 1-200 a.a. fragment of METTL3 interacts with translation initiation factor(s) to promote translation. Knockdown of METTL3 had no effect on the association of cap-binding proteins or translation initiation factors (Extended Data Fig. 3b ). Thus, formation of the translation initiation complex does not require METTL3. Conversely, the association of METTL3 with m 7 GTP-agarose was diminished using lysates depleted for CTIF, eIF4GI or eIF3b, supporting the notion that the Letter reSeArCH association of METTL3 with m 7 GTP-agarose is mediated through an interaction with general translation initiation factor(s) (Extended Data Fig. 3c) .
A large-scale purification and mass spectroscopy characterization of complexes containing Flag-METTL3 identified numerous translation factors (Extended Data Fig. 3d ). Gene Ontology analysis of the METTL3-interacting proteins identified 'mRNA metabolic processes' , 'RNA processing' and 'Translation' as the most significantly enriched categories (Extended Data Fig. 3e, f) . Considering this and our previous observation that METTL3 knockdown diminishes the association of eIF3 with cap-binding proteins in co-immunoprecipitation, we hypothesized that METTL3 might interact directly with certain component(s) of the multi-subunit eIF3 complex.
To test whether METTL3 interacts with any of the 13 subunit(s) of eIF3, recombinant METTL3 and 1-200 a.a. were used for far-western blotting with a purified human eIF3 complex (Extended Data Fig. 4e,  Fig. 1c ). METTL3 and 1-200 a.a. both specifically bound to a single band that probably corresponds to eIF3g, eIF3h, eIF3i, eIF3j or eIF3m (Fig. 1d ). To further confirm this interaction and to define the particular subunit(s) that interacts with METTL3, we individually expressed and purified the GST-tagged eIF3 subunits from bacteria (Extended Data Fig. 4f ) and tested them for binding to His-METTL3 using in vitro binding assays with either His-METTL3 or 1-200 a.a. METTL3 (and 1-200 a.a.) were found to specifically interact with eIF3h ( Fig. 1e ). The interaction between eIF3h with METTL3 was further confirmed using an anti-METTL3 antibody (that recognizes a 1-250 a.a. METTL3 epitope) to specifically disrupt this eIF3h-METTL3 interaction (Extended Data Fig. 4g ). Additional GST pull-down experiments identified the MPN (Mpr1p and Pad1p N-terminal) domain 13 as necessary and sufficient to interact with METTL3 (Extended Data Fig. 4h-j) . Notably, the MPN domain faces the solvent side of the ribosome and is probably accessible for interaction with METTL3 without impairing 80S assembly 13 .
An in situ proximity ligation assay (PLA) confirmed METTL3-eIF3h proximity in cells ( Fig. 1f ). Co-immunoprecipitation experiments revealed that the association of METTL3 with translation initiation factors is dependent on eIF3h ( Fig. 1g ). We next tested the functional interaction between METTL3 and eIF3h, and found that depletion of eIF3h abrogated enhanced translation by METTL3 ( Fig. 1h , Extended Data Fig. 4k -m). Overall, our results support a model whereby mRNA circularization and translation control is mediated by a specific METTL3-eIF3h interaction (Fig. 1i ).
We next examined the widespread effect of METTL3 on mRNA translation ( Fig. 2 , Extended Data Fig. 5 ). METTL3 depletion caused an increase in the 80S ribosome peak and a corresponding reduction of polyribosome peak ( Fig. 2a ). METTL3 depletion had a negligible effect on steady-state mRNA abundance whereas translation efficiency of a large subset (4,267) of mRNAs was reduced by at least twofold in METTL3-depleted cells ( Fig. 2b-d) . Comparison of these genes with previously reported METTL3 photoactivatable ribonucleosideenhanced crosslinking and immunoprecipitation (PAR-CLIP) data 14 identified 809 mRNAs that are both bound and translationally regulated by METTL3 ( Fig. 2d ). mRNAs on this list of METTL3 targets have on average longer 3′ UTRs compared to all mRNAs ( Fig. 2e ). Gene Ontology showed that these mRNAs are involved in tumour progression and apoptosis (Extended Data Fig. 5b ). Quantitative PCR with reverse transcription (RT-qPCR) analysis confirmed that METTL3 depletion had a modest effect on mRNA abundance (Extended Data Fig. 5c ), but strongly decreased translation of target mRNAs (Fig. 2f ). Moreover, neither global mRNA stability analysis by RNA sequencing (RNA-seq) ( Fig. 2g ) nor RT-qPCR analysis of individual genes (Extended Data Fig. 5d , e) showed any differences in mRNA stability upon METTL3 depletion. We isolated endogenous METTL3 mRNPs and confirmed the association with target mRNAs by RT-qPCR ( Fig. 2h , Extended Data Fig. 6a ). Western blotting showed decreased protein expression from these target mRNAs in the METTL3-knockdown samples ( Fig. 2i ), whereas analysis of mRNA sequencing data revealed that the splicing patterns of these target mRNAs was unaltered (Extended Data Fig. 6b ). Depletion of YTHDF1, a m 6 A-reader protein implicated in translational control, had no effect on the expression of these METTL3 targets 7 (Extended Data Fig. 6c ). Western blotting showed strongly reduced endogenous expression of bromodomaincontaining protein 4 (BRD4) upon knockdown of eIF3h without affecting BRD4 mRNA abundance or the levels of METTL3 protein ( Fig. 2j , Extended Data Fig. 6d ). Expression of a short-hairpin RNA (shRNA)-resistant Flag-METTL3 rescued the expression of BRD4 and CD9 proteins. However, expression of a catalytic mutant of METTL3 failed to recover target gene expression ( Fig. 2k ). METTL3 knockdown in A549 lung cancer cells similarly led to decreased expression of BRD4 and other targets (Fig. 2l 
Letter reSeArCH
and control A549 cells with the BRD4 inhibitor JQ1 revealed that the METTL3-depleted cells are more sensitive to pharmacological BRD4 inhibition ( Fig. 2m , n, Extended Data Fig. 6e ).
Considering that 1-200 a.a. is sufficient to directly interact with eIF3h ( Fig. 1 and Extended Data Fig. 4 ) and that 1-200 a.a. can promote translation in tethering experiments whereas 1-150 a.a. does not (Extended Data Fig. 2 ), we reasoned that a region between 150-200 a.a. must be important for the physical and functional METTL3-eIF3h interaction. Secondary structure predictions identified a putative alpha helix (150-161 a.a.) that is highly conserved in mammals 15, 16 (Extended Data Fig. 7a, b ). Moreover, 3D modelling identified a putative structured module 17 (Extended Data Fig. 7c ). We therefore generated a mutant version of METTL3 with a single amino acid substitution of a highly conserved alanine (A155P) to disrupt this putative helical structure. Co-immunoprecipitation confirmed substantially impaired interaction of METTL3(A155P) with translation initiation factors, specifically in RNase-treated samples (Fig. 3a) . Notably, the A155P mutation did not disrupt METTL3 interaction with METTL14 ( Fig. 3a) . Tethering experiments demonstrated that the METTL3(A155P) mutant is strongly impaired in promoting mRNA translation ( Fig. 3b , Extended Data Fig. 7d, e ). Moreover, expression of METTL3(A155P) in METTL3-depleted cells failed to rescue the expression of endogenous 
Letter reSeArCH target proteins (Fig. 3c ). This effect was not due to altered mRNA association of METTL3(A155P) with endogenous target mRNAs ( Fig. 3d and Extended Data Fig. 7f ). In summary, although the METTL3 A155P mutant can associate with METTL14 and be loaded on mRNAs, its ability to interact with initiation factors and promote mRNA translation is severely compromised.
We next used in vitro-reconstituted translation assays to explore the effect of 3′ UTR-bound METTL3 on translation efficiency and polysome conformation (Fig. 3e , f, Extended Data Figs. 7g, 9a). Consistent with Extended Data Fig. 1g , tethering of recombinant METTL3 increased translation efficiency with a stronger effect on mRNA lacking a poly(A) tail (Fig. 3e ). By contrast, tethered METTL3(A155P) had no significant effect on translation (Fig. 3e ). Electron microscopy analysis of samples from the in vitro translation reactions showed mostly densely packed polysome structures formed when METTL3 was tethered to reporter mRNAs lacking a poly(A) tail (Extended Data Fig. 9a ). By contrast, almost all the polysomes observed in the METTL3(A155P) sample appeared as linear polysomes (as in the control sample). Only dispersed ribosomes were observed in reactions without mRNA ( Fig. 3f , Extended Data Fig. 9a ). In all samples with mRNAs with poly(A) tails, mostly packed polysomes were observed irrespective of the protein that was tethered. As the reporter mRNA contains a very short 3′ UTR, it is expected that the known eIF4GI-PABP interaction is probably responsible for observed packed polysomes in poly(A) + samples ( Fig. 3f , Extended Data Fig. 9a ). We further analysed in vitro translation assays by sucrose gradient fractionation. Tethering of wildtype METTL3 resulted in a larger polysome peak compared to the METTL3(A155P) mutant ( Fig. 3g ). Individual polysomes were analysed using electron microscopy ( Fig. 3g, h ). Polysomes formed with wild-type METTL3 appeared to be more densely packed compared to the more linear polysomes that formed with the A155P mutant or MS2 control ( Fig. 3h ). Taken together, these results strongly support our model that METTL3 through its interaction with eIF3h promotes translation through its effects on polysome conformation.
Considering that METTL3 regulates the translation of a large subset of genes that are involved in tumour progression and apoptosis (Extended Data Fig. 5b ), we examined the role of METTL3 in cancer. Immunohistochemistry staining of primary human lung adenocarcinoma samples and adjacent normal control tissue revealed that METTL3 expression is significantly increased in lung tumours and correlates with tumour stage (Fig. 4a , b, Extended Data Fig. 8a ). METTL3 depletion in A549 lung cancer cells resulted in significantly smaller tumours in mouse xenografts ( Fig. 4c , Extended Data Fig. 8b-d) .
We next examined the relevance of the METTL3-eIF3h interaction and mRNA looping in the context of cancer-cell biology. Knockdown of eIF3h suppressed the ability of METTL3 to promote cellular invasion ( Fig. 4d , Extended Data Fig. 8e ). Moreover, unlike wild-type METTL3 protein, expression of either a catalytically inactive mutant or the METTL3(A155P) mutant was unable to promote the invasive capability of lung fibroblasts (Fig. 4e , Extended Data Fig. 8f ). Furthermore, METTL3 overexpression was sufficient to promote the oncogenic transformation of NIH-3T3 cells, mouse embryonic fibroblasts (MEFs) or MB352 (p53-null MEFs) cells, whereas METTL3(A155P) had no significant effect in these 3D soft agar colony formation assays ( Fig. 4f -h, Extended Data Fig. 8g, h) . The oncogenic function of METTL3 was also studied in the mouse xenografts. NIH-3T3 cells with ectopic expression of wild-type METTL3, METTL3(A155P) or the empty-vector control were injected into nude mice to determine their in vivo tumorigenic capacities. Overexpression of wild-type METTL3 promoted in vivo tumour growth, whereas METTL3(A155P) showed an impaired ability to promote tumour growth. As control, no tumours were detected in mice injected with control NIH-3T3 cells (Fig. 4i, Extended Data Fig. 8i ). Overall, these results support that the METTL3-eIF3h-mediated mRNA looping is critical for the oncogenic function of METTL3.
Methylated-RNA immunoprecipitation with sequencing (meRIPseq) performed on four primary human lung tumours identified patient-specific and commonly m 6 A-modified mRNAs in lung cancer (Extended Data Fig. 8j , Supplementary Table 3 ). An expected GGAC motif was identified and m 6 A peaks are predominantly localized near the translation stop codon ( Fig. 4j , k, Extended Data Fig. 8k ). Gene Ontology analysis revealed that the common methylated genes are enriched in the signature genes of neoplasms and cancer, including the known oncogenes EGFR and BRD4 (Fig. 4l, Extended Data Fig. 9b ). These data were consistent with m 6 A features identified in cell lines, with more than 50% of the peaks found in both tumours and cancer cell lines (Extended Data Fig. 9c ).
We propose that METTL3 promotes oncogene translation and tumorigenesis through a mRNA looping mechanism. This is supported by: 1) the position-dependent effects of METTL3 tethering on mRNA translation; 2) electron-microscopy visualization of METTL3 bound Letter reSeArCH to endogenous polyribosomes and its proximity to cap-binding proteins; 3) METTL3 interaction with eIF3h and 4) the disruption of METTL3-eIF3h interaction abolishes the ability of METTL3 to promote translation, affect polysome conformation or promote oncogenic transformation. This METTL3-eIF3h loop presumably promotes translation through ribosome recycling in a way similar to that proposed for eIF4G-PABPC1-mediated mRNA looping. Although there is probably some redundancy between these mRNA circularization mechanisms, looping between the stop codon and the 5′ end might represent a more productive way to recycle ribosomes rather than via the 3′ end, especially for mRNAs with long 3′ UTRs as the ribosomes will dissociate from the mRNP once released at the stop codon.
The complexity of eIF3 and the specialized roles of individual subunits are only beginning to be appreciated 18, 19 . Imbalanced expression of eIF3 subunits is found in various tumours 20 and expression in fibroblasts can promote malignant transformation 21 . Increased eIF3h expression is found in different tumour types and in many cases is due to amplification of a chromosomal region that includes EIF3H at 8q23.3 and the nearby MYC oncogene 22, 23 . METTL3 is overexpressed in many different types of cancer (Extended Data Fig. 10a ), and the expression of METTL3 and eIF3h is often positively correlated (Extended Data Fig. 10b, c) . Our findings could pave the way for the development of new cancer therapeutic strategies.
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MEthodS
Cell culture and transfection. Human lung cancer cell lines (A549 and H1299), HEK293T, BJ, NIH-3T3, HeLa cells and MEFs were cultured with DMEM supplemented with 10% fetal bovine serum (FBS) and antibiotics. Cells were grown in a 5% CO 2 cell culture incubator at 37 °C. Cell lines were authenticated using morphology-, karyotyping-and PCR-based approaches by ATCC. The cell lines were tested for potential mycoplasma contamination and confirmed that they are mycoplasma negative. Transfection of plasmids was performed using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. Down regulation of target genes by siRNA was performed using Lipofectamine RNAi Max (Invitrogen). The following siRNA sequences were used in this study: 5′-r(GAUAGAUGGCCUUGUGGUA)(UU)-3′ for eIF3h-1; 5′-r(GCGGAGCCU UCGCCAUGUA)(UU)-3′ for eIF3h-2; 5′-r(UGAGAAAGGAGGAGAGGAA) d(TT)-3′ for eIF4GI; 5′-r(UCAACCUCUUUACGGAUUU)d(TT)-3′ for eIF3b; and 5′-r(GCAUCAACCUGAAUGACAU)(UU)-3′ for CTIF.
Virus production and generation of stable knockdown and overexpression cells.
Virus-mediated generation of stable knockdown and overexpression cells were performed as previously described 1 . In brief, shRNA containing pLKO.1 vector was co-transfected with pLP1, pLP2, and VSVG into 293T cells. For overexpression, pCDH vectors containing the wild-type METTL3 (METTL3 WT) and A155P cDNA were co-transfected with Delta 8.9 and VSVG plasmids into 293T cells. Viruses were collected at 48 h and 72 h after transfection and then used to infect cells with Polybrene (8 mg/ml, Sigma); 48 h after infection, puromycin was added to the culture medium to select the infected cells. Plasmid construction. pFLAG-METTL3 WT, pFLAG-MS2-METTL3 and pFLAG-MS2-METTL3 Mut, have previously been described 1 For bacteria protein expression of human eIF3h, eIF3j and eIF3m that express N-terminal GST-fused proteins, BamHI/EcoRI fragment of pGEX2TK vector was ligated to the PCR amplified BamHI/EcoRI fragment that contained eIF3h, eIF3j or eIF3m. In addition, for the pGEX2TK-eIF3g or -eIF3i, BglII/EcoRI fragment of pGEX2TK vector was ligated to the PCR amplified BglII/EcoRI fragment that contained either eIF3g or eIF3i, respectively. For bacteria expression of eIF3h, deletion mutants were generated by ligation of BamHI/EcoRI fragment of pGEX2TK vector with BamHI/EcoRI fragment of either PCR-amplified eIF3h (1-222) or eIF3h (29-222). The pGL3c_TK luciferase reporter (FLuc) and pGL3c_TK luciferase reporter containing 2× MS2 binding sites near the stop codon (FLuc-MS2bs) have previously been described 1 . The 2× MS2 binding site sequence was PCR-amplified from FLuc-MS2bs and inserted into the NcoI site of pGL3c_TK luciferase reporter to make the FLuc-5′ UTR-MS2bs reporter that the MS2 binding sites are located in the 5′ UTR region of the luciferase gene. The 2× MS2 binding site sequence and GFP sequence (from CAG-GFP, Addgene Plasmid #16664) were cloned into the XbaI site of pGL3c_TK luciferase reporter (FLuc) to make the FLuc-MS2bs-GFP and FLuc-GFP-MS2bs reporters. For pFLAG-tethering effector plasmids, METTL3 shRNA resistance plasmids were generated by introducing synonymous mutations into the shRNA targeting sequence using the Q5 Site-Directed Mutagenesis Kit (NEB E0554). All cloning primers are listed in Supplementary Table 1 . In vitro translation assay. H1299 cells were collected and resuspended in hypotonic buffer (10 mM Hepes (pH 7.4), 10 mM potassium acetate, 1.5 mM magnesium acetate, and 2.5 mM dithiothreitol (DTT)). Cells were then incubated on ice for 30 min and ruptured by passing ten times through a 25-gauge needle attached to a 3-ml syringe. The cell homogenate was centrifuged at 13,000g for 15 min at 4 °C. The supernatant was collected and used for in vitro translation. In vitro translation reactions were performed for 1 h at 30 °C using either H1299 cytoplasmic cell extracts or rabbit reticulocyte lysate (RRL) (Thermo FisherScientific, AM1200) in 20-µl reaction mixtures containing 100 ng of in vitro transcribed reporter mRNAs and 500 ng of either purified recombinant His-Flag-MS2, His-Flag-MS2-METTL3 or His-Flag-MS2-METTL3 (1-200) protein. The activity of in vitrotranslated luciferase was measured using a Luciferase assay kit (Promega, E1960) according to the manufacturer's instructions. Reporter mRNAs either presence or absence of poly(A) tails were in vitro transcribed using PCR-amplified FLuc-MS2bs fragment with following primers; 5 ′-G A C
T A G T A A T A C G A CT C A C T A T A G G G
G C C A CC A T GG AA GACGCCAAAAACATAAAG-3′ (sense) and 5′-TCTAGA CCCCGGGAGCATGGGTGAT-3′ (antisense) for the FLuc-MS2bs Poly(A) − mRNA, and 5′-GACTAGTAATACGACTCACTATAGGGGCCACCATGGA AGACGCCAAAAACATAAAG-3′ (sense) and 5 ′-TTTTTTTTTTTTTTTTTTTT TTTTTTTTTTTCTAGACCCCGGGAGCATGGGTGAT-3′ (antisense) for the FLuc-MS2bs Poly(A) + mRNAs. RNA isolation and RT-qPCR. The details of RNA isolation and RT-qPCR assays are as previously described 1 . In brief, RNA was extracted from cells, co-immunoprecipitation or sucrose gradient fractionation samples using Trizol (Invitrogen) according to the manufacturer's instructions. RT-qPCR analyses were performed using SYBR Green PCR Master Mix with the Step One Real-Time PCR System (AppliedBiosystems). All primers used in this study are listed in Supplementary  Table 2 . For the analysis of global or individual mRNA lifetime, METTL3-depleted or control HeLa cells (60-mm culture dishes) were treated with actinomycin D (5 µg/ml), then collected after 0 h, 2 h, 4 h and 6 h. Luciferase assay and translation efficiency. Dual luciferase assays were performed according to the manufacturer's protocol (Promega). FLuc activity was normalized to the Renilla luciferase (RLuc) activity. Relative FLuc activity was normalized to the relative FLuc mRNAs. The normalized FLuc activity (translation efficiency) in the presence of Flag-MS2 was set to 1. Polysome fractionation and RNA-seq. METTL3-depleted or control HeLa cells (four 150-mm culture dishes) were treated with 100 µg/ml cycloheximide (Sigma) for 10 min at 37 °C. Cells were then lysed and layered onto 10-50% sucrose gradient tube and centrifuged at 36,000 r.p.m. in a Beckman SW-41Ti rotor for 2.5 h at 4 °C. Gradients were fractionated and monitored at absorbance 254 nm (Brandel). Collected fractions were pulled into sub-polysome fraction and polysome fraction. Then, total RNA, sub-polysome and polysome samples were subjected to RNA-seq. Poly(A)-selected mRNAs were purified and used for library construction using TruSeq Stranded mRNA Sample Prep Kits (Illumina RS-122-2101) and sequenced with Illumina NextSeq 500. ERCC RNA Spike-In Control Mixes (Ambion) were added into each sample before constructing the library to normalize the reads.
Co-immunoprecipitation, mass spectrometry and western blot.
Co-immunoprecipitation and western blot were performed as previously described 1 .
In brief, Flag-METTL3-expressing HeLa or H1299 cells were collected and lysed using NET-2 buffer (50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1 mM phenylmethanesulfonylfluoride (PMSF), 2 mM benzamidine, 1% NP-40) then the supernatant was subjected to immunoprecipitation using anti-Flag M2 Affinity Gel (Sigma-Aldrich). Where indicated, the affinity elute was subjected to SDS-PAGE and then either colloidal Coomassie blue staining or western blotting. Bands were excised and subjected to mass spectrometric sequencing as previously described 1 . The following antibodies were used for western blotting: METTL3 (Proteintech, 15073-1-AP; Abcam, ab195352), β-actin (Abcam, ab8227), eIF3h (Abcam, ab60942) CBP80 (gift from Y. K. Kim, Korea University), CTIF (gift from Y. K. Kim, Korea University), eIF4E (Cell Signaling Technology, #2067), eIF3b (Santa Cruz Biotechnology, sc-16377), eIF4GI (Cell Signaling Technology, #2498), Flag (Sigma, A8592), BRD4 (Abcam, ab128874), CD9 (Cell Signaling Technology, #13174), MGMT (Cell Signaling Technology, #2739), TIMP1 (Cell Signaling Technology, #8946) and FTO (Phosphosolution, 597-FTO). Protein expression, purification and GST pull-down assay. Plasmids expressing the recombinant proteins were transformed into BL21 Escherichia coli and then the recombinant proteins were induced by IPTG at 20 °C overnight. The bacteria were pelleted and resuspended in protease inhibitor containing PBST buffer and then lysed by sonication. His-tag recombinant proteins were purified using Ni-NTA agarose (Qiagen 30210). The GST-tagged proteins were purified using the glutathione sepharose (BioVision 6655) according to the manufacturer's protocol. For GST pull down assay, equal amount of GST fusion proteins or GST control bound to glutathione sepharose were incubated with purified recombinant His-tagged full-length METTL3 or N-terminal (1-200) fragment for 1 h at 4 °C, after extensive washing, the proteins bound to the sepharose were resolved on SDS-polyacrylamide gels and detected by western blot analysis. Far-western blotting. Far-western blotting was performed with biochemically purified human eIF3 protein complex that was resolved by SDS-PAGE and then transferred to Hybond ECL nitrocellulose membrane. The membrane was first incubated in blocking buffer (100 mM Tris (pH 7.5), 100 mM potassium acetate, 2 mM magnesium acetate, 0.1 mM EDTA, 10% glycerol, 1 mM PMSF, 1 mM benzamidine, and 0.05% Tween 20, 5% non-fat milk) at 4 °C overnight, then the membrane was incubated with blocking buffer containing 5 µg of purified recombinant full-length METTL3 or METTL3 (1-200) proteins at 4 °C for another 24 h. After that, the membrane was incubated with METTL3 antibody for western blotting analysis. Electron microscopy. Flag-METTL3 expressing H1299 cells were collected and lysed using NET-2 buffer, then the supernatant was subjected to immunoprecipitation using anti-Flag M2 Affinity Gel (Sigma-Aldrich). Resin-bound mRNP complexes were eluted using 3×Flag peptides (Sigma, F3290). Where indicated, during the elution, anti-METTL3 antibody (Proteintech, 15073-1-AP) and gold nanoparticle Letter reSeArCH (6 nm) conjugated anti-rabbit IgG were added with or without either anti-CBP80 antibody or anti-eIF4E antibody that was gold-nanoparticle (10 nm)-conjugated using GOLD conjugation kit (Abcam, ab201808), according to the manufacturer's instructions. The eluates were then fractionated using 10-50% sucrose gradients. Each fraction was applied to an electron-microscopy grid (EMS, G400-Cu) covered with a thin layer of carbon and after 1 min the excess suspension was blotted with a filter paper. The grid was washed twice with water and 0.7% uranyl formate, and then negatively stained for 20 s with 0.7% uranyl formate. The specimens were examined in Tecnai G2 Spirit BioTWIN Transmission Electron Microscope (FEI company) with AMT 2k CCD camera equipped. Direct magnification of 68,000× was used to detect images from Extended Data Fig. 9a , and magnification of 98,000× was used to detect images from Figs. 1b, 3h and Extended Data Fig. 4a , c. Polysome numbers were counted using 20 individual pictures for each sample with direct magnification of 30,000× in Fig. 3f . All the images shown in the figures are cropped sections. The average distance between immuno-gold particles in Extended Data Fig. 4d was measured from the images in Fig. 1b and Extended Data Fig. 4c using the electron microscope software (AMT Capture engine). In vitro translation reactions were performed for 1 h at 30 °C using RRL, and then the total reaction mixture was subjected to illustra MicroSpin S-400 HR Columns (Fig. 3f, Extended Data Fig. 9a ) or sucrose gradient fractionation (Fig. 3g, h) . The eluates were then applied to an electron-microscopy grid and analysed by electron microscopy. Cap-association assay using m 7 GTP-agarose. To analyse the interaction of METTL3 and the cap-binding protein complex, cells were lysed using NET2 buffer and total cell extracts were incubated with m 7 GTP-agarose (Jena Bioscience, AC-155S) for 2 h at 4 °C. Then, the beads were washed five times and suspended in SDS sample buffer. The eluted samples were analysed by western blot. Where indicated, 75 µM of m 7 G(5′)ppp(5′)G Cap Analogue (Ambion, AM8048) was added into the sample and incubated with m 7 GTP-agarose. Cell proliferation, apoptosis and invasion assays. Cell proliferation, apoptosis and invasion assays were performed as described 1 . In brief, for cell proliferation, 700 cells were seeded in a 96-well plate on day 0 with the pertinent treatment. JQ1 (500 nM) was used. Absorbances at 490 nm were measured using CellTiter 96 AQueous One Solution Cell Proliferation Assay kit (Promega) on day 2, day 4, and day 6 to measure the cellular proliferation. The numbers of apoptotic cells were quantified by flow cytometric assays using Annexin V-FITC Apoptosis Detection Kit (BioVision) five days after 500 nM of JQ1 treatment and cell seeding. Cell invasion was measured using BioCoat Matrigel Invasion Chamber (Corning) according to the manufacturer's instructions. Soft agar colony formation assays. NIH-3T3, MEFs and MB352 cells at 30% confluence were infected with the lentivirus expressing indicated protein for 48 h in the presence of 8 µg/ml polybrene (Sigma). Two days after infection, puromycin was added to the medium at 2.5 µg/ml, and cells were selected for 1 week. Fifty thousand live NIH-3T3 cells, 100,000 live MEFs or 100,000 live MB352 (p53 null MEFs) cells were selected and mixed with 0.35% top-agar and were plated onto 0.6% base-agar in six-well plates. Twenty-five days (NIH-3T3) or thirty days (MEFS or MB352) after plating the cells into soft agar, colony numbers were counted. The colony numbers were counted by openCFU. PLA. HeLa cells were incubated with primary antibodies (rabbit anti-METTL3 antibody and mouse anti-eIF3h antibody) in blocking solution at 4 °C for 2 h. Cells were then washed for five times for 5 min in PBS plus 0.1% Tween 20. Then, cells were incubated with secondary proximity probes (anti-Rabbit-PLUS and anti-Mouse-MINUS) (Sigma, DUO92101) for 90 min at 37 °C. Cells were washed five times for 5 min in 10 mM Tris-HCl (pH 7.5) plus 0.1% Tween 20 at 37 °C, then twice for 5 min in PBS plus 0.1% Tween 20. All subsequent steps were performed according to the manufacturer's instruction. Cells were observed with a Zeiss LSM 710 Multiphoton Laser Scanning Confocal. Immunohistochemistry staining. The human lung cancer tumour array was purchased from Biomax (HLug-Ade150CS-01). The slide was baked for 60 min in an oven set to 60 °C and then loaded into the Bond III staining platform with appropriate labels. Antigen was retrieved by Bond Epitope Retrieval 2 for 20 min. Then the slide was incubated with METLL3 antibody (Abcam, ab195352) at 1:500 for 30 min at room temperature. Primary antibody was detected using Bond Polymer Refine Detection kit. Slides were developed in DAB, then dehydrated and coverslipped. Each sample was scored by the percentage of positively stained cells (percentage score: 1-5) and the staining intensity (intensity score: 1-5). Then the sample staining score was calculated by multiplying the percentage score and the intensity score. In vivo tumour xenograft. All research involving animals complied with protocols approved by the Beth Israel Deaconess Medical Center Institutional Animal Care and Use Committee. Four-to-six-week-old female NU/J (Nude) immunodeficient mice (Jackson Laboratory #002019) were used for subcutaneous injections. Randomly divided five mice (A549 cells) or eight mice (NIH-3T3 cells) were used for each group. One hundred thousand A549 cells or 1,500,000 NIH-3T3 cells in serum-free medium and growth-factor-reduced Matrigel (Corning #354230) (1:1) were inoculated into the flank of nude mice. The xenograft tumour formation was monitored using callipers twice a week. The recipient mice were monitored and euthanized when the tumours reached 1-cm diameter. The tumour volume was calculated by use of a formula 1/2(length × width2). The investigator was blinded to group allocation. m 6 A meRIP-seq and data analysis. meRIP-seq was performed as previously described 1 . All the studies involving human patient samples complied with protocols approved by the Institutional Review Board. Informed consent was obtained from all participants. Portions of fresh tumour tissue approximately 0.5 × 0.5 × 0.5 cm were snap-frozen and preserved at −80 °C, pulverized in liquid nitrogen and stabilized in Trizol for total RNA isolation. Then, the mRNA purification from total RNA was performed using PolyATtract mRNA Isolation Systems (Promega). Two micrograms of the purified mRNA was fragmented and immunoprecipitated with anti-m 6 A antibody (Synaptic Systems, 202003). The purified RNA fragments from m 6 A MeRIP were used for library construction using the TruSeq Stranded mRNA Sample Prep Kits (Illumina RS-122-2101) and sequenced with Illumina NextSeq 500. Reads mapping, peak calling, metagene analysis and motif search were performed as previously described 1 . To identify the alternative splicing events, all the clean RNA-seq reads of control and METTL3 knockdown samples were first trimmed to the same length (72 bp), which were then aligned against the human hg19 (GRCh37) reference genome using Tophat2 24 . rMATS v.3.2.5 25 was used to detect the splicing events and significant splicing differences between METTL3 knockdown and control samples. To analyse the global profiling of mRNA lifetime, the clean reads were aligned to human reference genome (hg19) using Tophat2 24 after trimming the adapters and filtering low-quality sequences from the raw data. The reads mapped to each gene were counted using HTSeq 26 on the basis of the GENCODE gene model (v19) 27 . The raw counts were then normalized as reads per kilobase per million mapped reads. ERCC RNA Spike-In Control Mixes (Ambion) were added into each sample before constructing the library to normalize the reads. mRNA lifetime was calculated according to the method in the previous study 8 . To analyse METTL3 or eIF3h expression level among tumours from the Cancer Genome Analysis (TCGA), RNA-seq data for 33 TCGA tumour types were downloaded from Genomic Data Commons Data Portal (GDC) of TCGA (https://cancergenome.nih.gov/) using R package TCGAbiolinks 28 The expression matrix was then constructed by merging the transcripts per million values of all downloaded RNA-seq samples. The tumour types without corresponding normal tissue samples were excluded and the retained 24 tumour types with normal tissues were used to draw the box plot of gene expression. P values are calculated by Wilcoxon rank-sum test, with asterisks indicating statistical significance. Statistics and reproducibility. Data are presented as the mean ± s.e.m. or mean ± s.d. Statistical significance was determined by a Student's two-tailed t-test for RT-qPCRs and Luciferase assays. Where applicable, Shapiro-Wilk test and Q-Q plotting (quantile-quantile plot) were performed before Student' s two-tailed t-test to assess whether the data plausibly came from a normal distribution. Where indicated, Shapiro-Wilk signed-rank test was used. P < 0.05 was considered statistically significant. Sample size for Extended Data Fig. 10a, b ; n = 408, n = 1,095, n = 304, n = 36, n = 285, n = 184, n = 155, n = 520, n = 66, n = 533, n = 290, n = 371, n = 515, n = 501, n = 178, n = 179, n = 497, n = 94, n = 259, n = 103, n = 415, n = 505, n = 120 and n = 176, from the order of left to right for primary solid tumour; n = 19, n = 133, n = 3, n = 9, n = 41, n = 11, n = 5, n = 44, n = 25, n = 72, n = 32, n = 50, n = 59, n = 51, n = 4, n = 3, n = 52, n = 10, n = 2, n = 1, n = 35, n = 59, n = 2 and n = 24, from the order of left to right for normal tissue. Sample size for Extended Data Fig. 10c ; n = 285, n = 184, n = 155, n = 371, n = 515, n = 501, n = 497 and n = 94, from the order of left to right. Code availability. Script and code used for data analysis can be found at https:// github.com/rnabioinfor/rnamethy. Reporting summary. Further information on experimental design is available in the Nature Research Reporting Summary linked to this paper.
Data availability
The m 6 A meRIP-seq and RNA-seq data have been deposited in the Gene Expression Omnibus (GEO) under accession number GSE117299. All other data are available from the authors on request. A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
Letter reSeArCH
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Our web collection on statistics for biologists may be useful.
Software and code
Policy information about availability of computer code
Data collection
To analyze METTL3 or eIF3h expression level among TCGA tumors, RNA-Seq data for TCGA tumor types were downloaded from Genomic Data Commons Data Portal (GDC) of TCGA (http://cancergenome.nih.gov/) using R package TCGAbiolinks.
Data analysis
For high throughput sequencing data analysis, reads were aligned against the human hg19 (GRCh37) reference genome using Tophat2, rMATS v3.2.5 was used to detect the splicing events and significant splicing differences between METTL3 knockdown and control samples; MACS2.1.0 was used for the peak calling in m6A peak identification; mRNA half-life was calculated using the RPKM generated by HTSeq.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
Validation
The antibodies that have been validated by the supplyers for specific purposes (for example, western blot) were purchased for our experiment. In addition, for key essential antibodies such as METTL3, eIF3h antibodies, we further validated the antibodies by western blotting upon depletion of the proteins. For 
Authentication
Cell lines were authenticated with morphology, karyotyping, and PCR based approaches by ATCC
Mycoplasma contamination
The cell lines were tested for potential mycoplasma contamination and confirmed that they are mycoplasma negative.
Commonly misidentified lines (See ICLAC register)
No commonly misidentified cell lines were used in this study.
Animals and other organisms
Policy information about studies involving animals; ARRIVE guidelines recommended for reporting animal research Laboratory animals All research involving animals was complied with protocols approved by the Beth Israel Deaconess Medical Center Institutional Animal Care and Use Committee. 4-6 weeks old female NU/J (Nude) immunodeficient mice (Jackson Laboratory #002019) were used for subcutaneous injections.
Wild animals
The study did not involve wild animals.
Field-collected samples
The study did not involve samples collected from the field.
Human research participants
Policy information about studies involving human research participants
Population characteristics
Lung cancer tumor samples were isolated from four patients (Patient 1: Female, Age 73 mixed subtype, with acinar (10%), papillary (80%),and bronchioloalveolar (10%) patterns, moderately differentiated, 5.1cm; Patient 2: Male, Age 80, mixed subtype with 80% papillary, 14% acinar, 5% bronchioloalveolar, and 1% solid patterns, moderately differentiated, 8cm. Patient 3: Male, Age 79 with acinar (20%), papillary (60%), andbronchioloalveolar (20%) patterns, moderately differentiated, 5.0cm; Patient 4: Female, age 61, lung adenocarcinoma, micropapillary predominant, with solid, acinar and papillary areas, poorly differentiated, 10.5 cm). Recruitment lung adenocarcima samples from four patients (two males and two females) were used for the profiling of m6A modification in primary tumor tissues. Since this is a pilot study of m6A in primary lung cancer samples, we selected the patients with large size tumors so that we can get enough RNA samples for m6A profiling, there is no potential self-selection bias.
